Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.665 USD | +0.19% | +6.57% | -34.60% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.60% | 353M | |
+48.93% | 56.95B | |
+39.69% | 40.26B | |
-7.53% | 39.32B | |
-5.96% | 28.37B | |
+11.96% | 26.45B | |
-18.21% | 19.41B | |
+29.95% | 12.54B | |
+24.75% | 12.21B | |
-1.57% | 12.15B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Oppenheimer Downgrades Organogenesis Holdings to Perform From Outperform, Removes $14 Price Target